In the second edition of UC Davis LIVE: COVID-19, two UC Davis clinicians will talk about and take questions on the new treatments for COVID-19 being tested at UC Davis Health and other hospitals, including the experimental antiviral drug remdesivir — used to treat UC Davis’ first patient of the pandemic in March — and using plasma from people who have recovered from the novel coronavirus to treat patients.
The guests are , director of transfusion medicine and assistant clinical professor in the ; and , professor of internal medicine and chief of the